AI-Enhanced App for Nicotine Addiction

Overseen By Eunhee Park, PhD, RN, APHN-BC

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: State University of New York at Buffalo

Disqualifiers: Age, No e-cigarette use, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

100 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this quasi-experimental study is to test if a smartphone app can help adolescents aged 14-20 quit e-cigarettes. The main questions it aims to answer are: * Can the app help adolescents manage cravings and increase their readiness to quit? * Does the personalized and real-time support provided by the app improve their success in quitting e-cigarettes? Researchers will compare two groups: an immediate-intervention group that starts using the app right away and a delayed-intervention group that begins after three months, to see if the timing of app access influences outcomes in e-cigarette cessation. Participants will: * Set personal goals and track their daily progress within the app. * Use a real-time "urge" feature that provides immediate support during cravings. * Engage with a chatbot for quick answers and motivational support around quitting. This study aims to create an accessible, personalized tool to help adolescents reduce or quit e-cigarette use, exploring its feasibility as a broader intervention model.

Eligibility Criteria

This trial is for adolescents aged 14-20 who are trying to quit e-cigarettes. Participants should be willing to use a smartphone app and engage with its features, like setting goals and tracking progress. There's no mention of specific exclusions in the provided information.

Inclusion Criteria

Currently use nicotine-containing e-cigarettes

I want to quit using e-cigarettes.

Owners of an iPhone or Android smartphone who use their phone daily

Exclusion Criteria

Those who have not used a nicotine-containing e-cigarette in the past 30 days

Adolescents who do not own or regularly use an iPhone or Android smartphone

Non-English speakers

Timeline

Development and Usability Testing

Participants test the app and provide feedback on usability and design to refine the app for deployment.

Not specified

Clinical Feasibility Testing

Participants use the app to assess its impact on readiness to quit, quitting attempts, and motivation over time.

3 months

Follow-up

Participants are monitored for engagement and changes in e-cigarette use, including readiness to quit and quit attempts.

3 months

Treatment Details

Interventions

• AI-Enhanced App-based Intervention

Trial Overview The study tests an AI-enhanced smartphone app designed to help young people stop using e-cigarettes. It compares immediate access to the app against delayed access after three months, examining if timing affects quitting success.

Participant Groups

Group I: Immediate-Intervention Group Experimental Treatment 1 Intervention

Participants in this arm will begin using the AI-enhanced smartphone app immediately after enrollment. This arm serves to assess the initial impact and feasibility of the app as a tool for e-cigarette cessation among adolescents.

Group II: Delayed-Intervention Group Active Control 1 Intervention

Participants in this arm will wait three months after enrollment before using the AI-enhanced smartphone app. This arm serves as a delayed control, allowing comparison with the immediate-intervention group to understand the impact of timing on quitting success.

Who Is Running the Clinical Trial?

State University of New York at Buffalo

Lead Sponsor

Trials

279

Recruited

52,600+

Advanced Bionics

Industry Sponsor

Trials

17

Recruited

500+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+